NUS Medicine's WisDM researchers used AI platform CURATE.AI to treat a patient with Waldenström macroglobulinemia, a rare blood disorder. The platform, designed for rare diseases, leverages small data sets to personalize treatments, dynamically adjusting dosages based on patient responses. The patient experienced significant improvements, fewer hospital admissions, and lower medication costs, with initial trial results published in 'NPJ Digital Medicine'.